Press Releases
-
Oct18
Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China
RUTHERFORD, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Oct16
Cancer Genetics Issues Letter to Shareholders
RUTHERFORD, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision
-
Oct8
Cancer Genetics and Cellaria Partner on Precision Medicine Tools
Collaboration focused on developing pharmacology models to support biopharma R&D RUTHERFORD, N.J., Oct. 08, 2018
-
Sep25
Cancer Genetics Enters Supply Agreement with Agilent Technologies
Probes for CGI’s FISH-based HPV-Associated Cancer Test (FHACT®) test to be manufactured by Agilent RUTHERFORD,
-
Sep20
Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials
RUTHERFORD, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Sep18
Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge
Transaction to Create a Leader in Precision Oncology RUTHERFORD, N.J. and JERUSALEM, Sept. 18, 2018 (GLOBE
-
Aug14
Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
Conference call at 8:30 a.m. ET, Tuesday, August 14, 2018 RUTHERFORD, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) --
-
Aug7
Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018
Conference call at 8:30 a.m. EDT, Tuesday, August 14, 2018 RUTHERFORD, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) --
-
Jul18
Cancer Genetics Closes $2.625 million Convertible Note Financing
RUTHERFORD, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling
-
Jun12
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
Executive appointment underscores continued execution of new corporate strategy of expanding Biopharma and Discovery
